当前位置:首页 - 行情中心 - 德源药业(920735) - 财务分析 - 现金流量表

德源药业

(920735)

  

流通市值:25.76亿  总市值:29.13亿
流通股本:1.14亿   总股本:1.29亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金836,406,215.07558,550,168.2277,324,279.171,063,419,134.48
  收到的税费返还17,754.2417,754.24-3,244,477.67
  收到其他与经营活动有关的现金9,790,219.339,366,834.068,220,622.2131,372,329.26
  经营活动现金流入小计846,214,188.64567,934,756.5285,544,901.381,098,035,941.41
  购买商品、接受劳务支付的现金126,214,074.2378,133,792.8934,951,153.96149,673,660.59
  支付给职工以及为职工支付的现金158,680,980.34109,553,869.360,812,279.36182,915,721.96
  支付的各项税费115,753,697.3384,649,186.8945,171,988.52142,858,246.9
  支付其他与经营活动有关的现金330,775,514.24228,451,228.57109,782,445.74465,921,228.07
  经营活动现金流出小计731,424,266.14500,788,077.65250,717,867.58941,368,857.52
  经营活动产生的现金流量净额114,789,922.567,146,678.8534,827,033.8156,667,083.89
二、投资活动产生的现金流量:
  取得投资收益收到的现金5,965,542.844,681,247.211,442,878.735,765,411.67
  处置固定资产、无形资产和其他长期资产收回的现金净额86,44846,088-9,856.31
  收到的其他与投资活动有关的现金880,470,666.67660,272,416.67280,000,0001,860,600,000
  投资活动现金流入小计886,522,657.51664,999,751.88281,442,878.731,866,375,267.98
  购建固定资产、无形资产和其他长期资产支付的现金36,134,007.5525,507,362.566,871,388.1853,224,934.51
  支付其他与投资活动有关的现金858,952,416.67638,952,416.67270,952,416.672,121,120,750
  投资活动现金流出小计895,086,424.22664,459,779.23277,823,804.852,174,345,684.51
  投资活动产生的现金流量净额-8,563,766.71539,972.653,619,073.88-307,970,416.53
三、筹资活动产生的现金流量:
  取得借款收到的现金4,163,052.561,587,500245,0008,790,000
  收到其他与筹资活动有关的现金3,805,509.262,664,888.38--
  筹资活动现金流入小计7,968,561.824,252,388.38245,0008,790,000
  偿还债务支付的现金---27,090,000
  分配股利、利润或偿付利息支付的现金47,103,924.2447,038,145.251,705.0836,378,914.79
  支付其他与筹资活动有关的现金1,409,228.12626,251594,450901,404
  筹资活动现金流出小计48,513,152.3647,664,396.2646,155.0864,370,318.79
  筹资活动产生的现金流量净额-40,544,590.54-43,412,007.82-401,155.08-55,580,318.79
五、现金及现金等价物净增加额65,681,565.2524,274,643.6838,044,952.6-206,883,651.43
  加:期初现金及现金等价物余额97,094,952.8697,094,952.8697,094,952.86303,978,604.29
  期末现金及现金等价物余额162,776,518.11121,369,596.54135,139,905.4697,094,952.86
补充资料:
  净利润-128,659,223.95-236,929,075.58
  资产减值准备-1,485,009.12-4,023,580.81
  固定资产和投资性房地产折旧-23,107,420.55-25,815,556.91
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-23,107,420.55-25,815,556.91
  无形资产摊销-762,446.76-1,524,893.52
  长期待摊费用摊销-125,280.36-284,609.38
  处置固定资产、无形资产和其他长期资产的损失-41,685.14-26,532.78
  固定资产报废损失-15.04-106,520.03
  公允价值变动损失--765,534.25--720,457.53
  财务费用-166,635.71-421,903.12
  投资损失--3,981,779.37--8,269,312.65
  递延所得税--957,793.6--2,786,367.95
  其中:递延所得税资产减少--1,204,815.56--2,640,546.07
    递延所得税负债增加-247,021.96--145,821.88
  存货的减少--24,593,008.64--16,807,802.23
  经营性应收项目的减少--109,886,499.06--132,502,292.03
  经营性应付项目的增加-50,548,737.8-47,677,864.34
  现金的期末余额-121,369,596.54-97,094,952.86
  减:现金的期初余额-97,094,952.86-303,978,604.29
  现金及现金等价物的净增加额-24,274,643.68--206,883,651.43
公告日期2026-10-292026-08-252026-04-282026-03-05
审计意见(境内)标准无保留意见
TOP↑